COLL Stock: Collegium Pharmaceutical, Inc. Stock Price, Analysis & Insights
Get live COLL stock price $34.63, comprehensive Collegium Pharmaceutical, Inc. stock analysis, charts, news, and expert forecast. Real-time COLL stock data and investment insights.
Loading chart data...
Collegium Pharmaceutical, Inc. (COLL) Overview
Collegium Pharmaceutical, Inc. (COLL) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, COLL trades at $34.63 with a market capitalization of 1.12B . Over the past 52 weeks, COLL has traded between $29.08 and $50.79 , with the current price positioned at approximately 26% of this ...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 1.12B
- Current price: $34.63
- 52-week range: $29.08 - $50.79
- P/E ratio: 16.81
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain condi...
Company Information
- CEO
- Vikram Karnani
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 357
Contact Information
- Address
- 100 Technology Center Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 16.8)
✓ Lower volatility stock (Beta: 0.75) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Collegium Pharmaceutical, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Collegium Pharmaceutical, Inc.
- ⚠Investors should consider how Collegium Pharmaceutical, Inc. fits within their overall portfolio allocation
Market Cap
1.12B
P/E Ratio (TTM)
16.81
Beta
0.75
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare COLL with peer companies:
- Price
- $20.17
- Market cap
- 889.39M
- Price
- $3.85
- Market cap
- 1.42B
- Price
- $2.75
- Market cap
- 1.03B
- Price
- $15.50
- Market cap
- 1.82B
- Price
- $2.57
- Market cap
- 889.10M
- Price
- $22.91
- Market cap
- 1.69B
- Price
- $3.66
- Market cap
- 544.40M
- Price
- $57.00
- Market cap
- 1.11B
- Price
- $23.45
- Market cap
- 922.33M
- Price
- $24.90
- Market cap
- 1.72B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.